A pilot study of tazemetostat and MK-3475 (pembrolizumab) in advanced urothelial carcinoma (ETCTN 10183).

Joshua J. Meeks,Ali Shilatifard,Stephen D. Miller,Alicia K. Morgans,David James VanderWeele,Masha Kocherginsky,Maha Hussain

A pilot study of tazemetostat and MK-3475 (pembrolizumab) in advanced urothelial carcinoma (ETCTN 10183).

2020

Joshua J. Meeks
Ali Shilatifard
Stephen D. Miller
Alicia K. Morgans
David James VanderWeele
Masha Kocherginsky
Maha Hussain

TPS607Background: Few patients with metastatic urothelial carcinoma (UC) achieve a durable response despite early stabilization with chemotherapy or immunotherapy. Mutations in the COMPASS-related ...

Keywords:

Immunotherapy
Metastatic Urothelial Carcinoma
Oncology
Pathology
Internal medicine
Carcinoma
Pembrolizumab
Tazemetostat
Medicine
Chemotherapy
urothelial carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations